Application | Comment | Organism |
---|---|---|
medicine | Onchocerca volvulus antigens possibly involved in protection against human onchocerciasis, GAPDH as a therapeutic target in helminth infections | Onchocerca volvulus |
Cloned (Comment) | Organism |
---|---|
into the pJC45Flag vector for expression in the Escherichia coli strain PAPlaclQ DE3, into the vaccination vector pcDNA3.1+ for transformation of DH5alpha cells | Onchocerca volvulus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
nucleus | nucleus of hypodermis | Onchocerca volvulus | 5634 | - |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
38000 | - |
calculated | Onchocerca volvulus |
38000 | - |
SDS-PAGE and immunoblot | Onchocerca volvulus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Onchocerca volvulus | - |
- |
- |
Purification (Comment) | Organism |
---|---|
by Ni2+ chelate chromatography and pH-shift under denaturating conditions | Onchocerca volvulus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
hypodermis | - |
Onchocerca volvulus | - |
uterine epithelium | - |
Onchocerca volvulus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
740 | - |
NADH-enzyme activity | Onchocerca volvulus |
Synonyms | Comment | Organism |
---|---|---|
GAPDH | - |
Onchocerca volvulus |
glyceraldehyde-3-phosphate dehydrogenase | - |
Onchocerca volvulus |
Ov-GAPDH | - |
Onchocerca volvulus |